Dalfampridine Market - Global Outlook and Forecast 2022-2028

March 2022 | 74 pages | ID: DDE0BCF88EC9EN
Market Monitor Global

Abstracts

Dalfampridine is a potassium channel blocker used to help multiple sclerosis patients walk. This is the first drug that was specifically approved to help with mobility in these patients.

This report contains market size and forecasts of Dalfampridine in global, including the following market information:

Global Dalfampridine Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Dalfampridine Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Dalfampridine companies in 2021 (%)

The global Dalfampridine market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

10 mg Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Dalfampridine include Acorda Therapeutics, Elan Pharma, Biogen, Sun Pharmaceutical and Aurobindo Pharma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Dalfampridine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Dalfampridine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Dalfampridine Market Segment Percentages, by Type, 2021 (%)

• 10 mg
• Others

Global Dalfampridine Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Dalfampridine Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Clinics
• Others

Global Dalfampridine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Dalfampridine Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Dalfampridine revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Dalfampridine revenues share in global market, 2021 (%)

Key companies Dalfampridine sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Dalfampridine sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Acorda Therapeutics
• Elan Pharma
• Biogen
• Sun Pharmaceutical
• Aurobindo Pharma

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Dalfampridine Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Dalfampridine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL DALFAMPRIDINE OVERALL MARKET SIZE

2.1 Global Dalfampridine Market Size: 2021 VS 2028
2.2 Global Dalfampridine Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Dalfampridine Sales: 2017-2028

3 COMPANY LANDSCAPE

3.1 Top Dalfampridine Players in Global Market
3.2 Top Global Dalfampridine Companies Ranked by Revenue
3.3 Global Dalfampridine Revenue by Companies
3.4 Global Dalfampridine Sales by Companies
3.5 Global Dalfampridine Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Dalfampridine Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Dalfampridine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Dalfampridine Players in Global Market
  3.8.1 List of Global Tier 1 Dalfampridine Companies
  3.8.2 List of Global Tier 2 and Tier 3 Dalfampridine Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Dalfampridine Market Size Markets, 2021 & 2028
  4.1.2 10 mg
  4.1.3 Others
4.2 By Type - Global Dalfampridine Revenue & Forecasts
  4.2.1 By Type - Global Dalfampridine Revenue, 2017-2022
  4.2.2 By Type - Global Dalfampridine Revenue, 2023-2028
  4.2.3 By Type - Global Dalfampridine Revenue Market Share, 2017-2028
4.3 By Type - Global Dalfampridine Sales & Forecasts
  4.3.1 By Type - Global Dalfampridine Sales, 2017-2022
  4.3.2 By Type - Global Dalfampridine Sales, 2023-2028
  4.3.3 By Type - Global Dalfampridine Sales Market Share, 2017-2028
4.4 By Type - Global Dalfampridine Price (Manufacturers Selling Prices), 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Dalfampridine Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Clinics
  5.1.4 Others
5.2 By Application - Global Dalfampridine Revenue & Forecasts
  5.2.1 By Application - Global Dalfampridine Revenue, 2017-2022
  5.2.2 By Application - Global Dalfampridine Revenue, 2023-2028
  5.2.3 By Application - Global Dalfampridine Revenue Market Share, 2017-2028
5.3 By Application - Global Dalfampridine Sales & Forecasts
  5.3.1 By Application - Global Dalfampridine Sales, 2017-2022
  5.3.2 By Application - Global Dalfampridine Sales, 2023-2028
  5.3.3 By Application - Global Dalfampridine Sales Market Share, 2017-2028
5.4 By Application - Global Dalfampridine Price (Manufacturers Selling Prices), 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Dalfampridine Market Size, 2021 & 2028
6.2 By Region - Global Dalfampridine Revenue & Forecasts
  6.2.1 By Region - Global Dalfampridine Revenue, 2017-2022
  6.2.2 By Region - Global Dalfampridine Revenue, 2023-2028
  6.2.3 By Region - Global Dalfampridine Revenue Market Share, 2017-2028
6.3 By Region - Global Dalfampridine Sales & Forecasts
  6.3.1 By Region - Global Dalfampridine Sales, 2017-2022
  6.3.2 By Region - Global Dalfampridine Sales, 2023-2028
  6.3.3 By Region - Global Dalfampridine Sales Market Share, 2017-2028
6.4 North America
  6.4.1 By Country - North America Dalfampridine Revenue, 2017-2028
  6.4.2 By Country - North America Dalfampridine Sales, 2017-2028
  6.4.3 US Dalfampridine Market Size, 2017-2028
  6.4.4 Canada Dalfampridine Market Size, 2017-2028
  6.4.5 Mexico Dalfampridine Market Size, 2017-2028
6.5 Europe
  6.5.1 By Country - Europe Dalfampridine Revenue, 2017-2028
  6.5.2 By Country - Europe Dalfampridine Sales, 2017-2028
  6.5.3 Germany Dalfampridine Market Size, 2017-2028
  6.5.4 France Dalfampridine Market Size, 2017-2028
  6.5.5 U.K. Dalfampridine Market Size, 2017-2028
  6.5.6 Italy Dalfampridine Market Size, 2017-2028
  6.5.7 Russia Dalfampridine Market Size, 2017-2028
  6.5.8 Nordic Countries Dalfampridine Market Size, 2017-2028
  6.5.9 Benelux Dalfampridine Market Size, 2017-2028
6.6 Asia
  6.6.1 By Region - Asia Dalfampridine Revenue, 2017-2028
  6.6.2 By Region - Asia Dalfampridine Sales, 2017-2028
  6.6.3 China Dalfampridine Market Size, 2017-2028
  6.6.4 Japan Dalfampridine Market Size, 2017-2028
  6.6.5 South Korea Dalfampridine Market Size, 2017-2028
  6.6.6 Southeast Asia Dalfampridine Market Size, 2017-2028
  6.6.7 India Dalfampridine Market Size, 2017-2028
6.7 South America
  6.7.1 By Country - South America Dalfampridine Revenue, 2017-2028
  6.7.2 By Country - South America Dalfampridine Sales, 2017-2028
  6.7.3 Brazil Dalfampridine Market Size, 2017-2028
  6.7.4 Argentina Dalfampridine Market Size, 2017-2028
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Dalfampridine Revenue, 2017-2028
  6.8.2 By Country - Middle East & Africa Dalfampridine Sales, 2017-2028
  6.8.3 Turkey Dalfampridine Market Size, 2017-2028
  6.8.4 Israel Dalfampridine Market Size, 2017-2028
  6.8.5 Saudi Arabia Dalfampridine Market Size, 2017-2028
  6.8.6 UAE Dalfampridine Market Size, 2017-2028

7 MANUFACTURERS & BRANDS PROFILES

7.1 Acorda Therapeutics
  7.1.1 Acorda Therapeutics Corporate Summary
  7.1.2 Acorda Therapeutics Business Overview
  7.1.3 Acorda Therapeutics Dalfampridine Major Product Offerings
  7.1.4 Acorda Therapeutics Dalfampridine Sales and Revenue in Global (2017-2022)
  7.1.5 Acorda Therapeutics Key News
7.2 Elan Pharma
  7.2.1 Elan Pharma Corporate Summary
  7.2.2 Elan Pharma Business Overview
  7.2.3 Elan Pharma Dalfampridine Major Product Offerings
  7.2.4 Elan Pharma Dalfampridine Sales and Revenue in Global (2017-2022)
  7.2.5 Elan Pharma Key News
7.3 Biogen
  7.3.1 Biogen Corporate Summary
  7.3.2 Biogen Business Overview
  7.3.3 Biogen Dalfampridine Major Product Offerings
  7.3.4 Biogen Dalfampridine Sales and Revenue in Global (2017-2022)
  7.3.5 Biogen Key News
7.4 Sun Pharmaceutical
  7.4.1 Sun Pharmaceutical Corporate Summary
  7.4.2 Sun Pharmaceutical Business Overview
  7.4.3 Sun Pharmaceutical Dalfampridine Major Product Offerings
  7.4.4 Sun Pharmaceutical Dalfampridine Sales and Revenue in Global (2017-2022)
  7.4.5 Sun Pharmaceutical Key News
7.5 Aurobindo Pharma
  7.5.1 Aurobindo Pharma Corporate Summary
  7.5.2 Aurobindo Pharma Business Overview
  7.5.3 Aurobindo Pharma Dalfampridine Major Product Offerings
  7.5.4 Aurobindo Pharma Dalfampridine Sales and Revenue in Global (2017-2022)
  7.5.5 Aurobindo Pharma Key News

8 GLOBAL DALFAMPRIDINE PRODUCTION CAPACITY, ANALYSIS

8.1 Global Dalfampridine Production Capacity, 2017-2028
8.2 Dalfampridine Production Capacity of Key Manufacturers in Global Market
8.3 Global Dalfampridine Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 DALFAMPRIDINE SUPPLY CHAIN ANALYSIS

10.1 Dalfampridine Industry Value Chain
10.2 Dalfampridine Upstream Market
10.3 Dalfampridine Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Dalfampridine Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Key Players of Dalfampridine in Global Market
Table 2. Top Dalfampridine Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Dalfampridine Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Dalfampridine Revenue Share by Companies, 2017-2022
Table 5. Global Dalfampridine Sales by Companies, (K Units), 2017-2022
Table 6. Global Dalfampridine Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Dalfampridine Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Dalfampridine Product Type
Table 9. List of Global Tier 1 Dalfampridine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Dalfampridine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Dalfampridine Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Dalfampridine Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Dalfampridine Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Dalfampridine Sales (K Units), 2017-2022
Table 15. By Type - Global Dalfampridine Sales (K Units), 2023-2028
Table 16. By Application – Global Dalfampridine Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Dalfampridine Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Dalfampridine Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Dalfampridine Sales (K Units), 2017-2022
Table 20. By Application - Global Dalfampridine Sales (K Units), 2023-2028
Table 21. By Region – Global Dalfampridine Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Dalfampridine Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Dalfampridine Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Dalfampridine Sales (K Units), 2017-2022
Table 25. By Region - Global Dalfampridine Sales (K Units), 2023-2028
Table 26. By Country - North America Dalfampridine Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Dalfampridine Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Dalfampridine Sales, (K Units), 2017-2022
Table 29. By Country - North America Dalfampridine Sales, (K Units), 2023-2028
Table 30. By Country - Europe Dalfampridine Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Dalfampridine Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Dalfampridine Sales, (K Units), 2017-2022
Table 33. By Country - Europe Dalfampridine Sales, (K Units), 2023-2028
Table 34. By Region - Asia Dalfampridine Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Dalfampridine Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Dalfampridine Sales, (K Units), 2017-2022
Table 37. By Region - Asia Dalfampridine Sales, (K Units), 2023-2028
Table 38. By Country - South America Dalfampridine Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Dalfampridine Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Dalfampridine Sales, (K Units), 2017-2022
Table 41. By Country - South America Dalfampridine Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Dalfampridine Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Dalfampridine Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Dalfampridine Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Dalfampridine Sales, (K Units), 2023-2028
Table 46. Acorda Therapeutics Corporate Summary
Table 47. Acorda Therapeutics Dalfampridine Product Offerings
Table 48. Acorda Therapeutics Dalfampridine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. Elan Pharma Corporate Summary
Table 50. Elan Pharma Dalfampridine Product Offerings
Table 51. Elan Pharma Dalfampridine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. Biogen Corporate Summary
Table 53. Biogen Dalfampridine Product Offerings
Table 54. Biogen Dalfampridine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Sun Pharmaceutical Corporate Summary
Table 56. Sun Pharmaceutical Dalfampridine Product Offerings
Table 57. Sun Pharmaceutical Dalfampridine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. Aurobindo Pharma Corporate Summary
Table 59. Aurobindo Pharma Dalfampridine Product Offerings
Table 60. Aurobindo Pharma Dalfampridine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. Dalfampridine Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 62. Global Dalfampridine Capacity Market Share of Key Manufacturers, 2020-2022
Table 63. Global Dalfampridine Production by Region, 2017-2022 (K Units)
Table 64. Global Dalfampridine Production by Region, 2023-2028 (K Units)
Table 65. Dalfampridine Market Opportunities & Trends in Global Market
Table 66. Dalfampridine Market Drivers in Global Market
Table 67. Dalfampridine Market Restraints in Global Market
Table 68. Dalfampridine Raw Materials
Table 69. Dalfampridine Raw Materials Suppliers in Global Market
Table 70. Typical Dalfampridine Downstream
Table 71. Dalfampridine Downstream Clients in Global Market
Table 72. Dalfampridine Distributors and Sales Agents in Global Market

List Of Figures

LIST OF FIGURES

Figure 1. Dalfampridine Segment by Type
Figure 2. Dalfampridine Segment by Application
Figure 3. Global Dalfampridine Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Dalfampridine Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Dalfampridine Revenue, 2017-2028 (US$, Mn)
Figure 7. Dalfampridine Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Dalfampridine Revenue in 2021
Figure 9. By Type - Global Dalfampridine Sales Market Share, 2017-2028
Figure 10. By Type - Global Dalfampridine Revenue Market Share, 2017-2028
Figure 11. By Type - Global Dalfampridine Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Dalfampridine Sales Market Share, 2017-2028
Figure 13. By Application - Global Dalfampridine Revenue Market Share, 2017-2028
Figure 14. By Application - Global Dalfampridine Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Dalfampridine Sales Market Share, 2017-2028
Figure 16. By Region - Global Dalfampridine Revenue Market Share, 2017-2028
Figure 17. By Country - North America Dalfampridine Revenue Market Share, 2017-2028
Figure 18. By Country - North America Dalfampridine Sales Market Share, 2017-2028
Figure 19. US Dalfampridine Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Dalfampridine Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Dalfampridine Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Dalfampridine Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Dalfampridine Sales Market Share, 2017-2028
Figure 24. Germany Dalfampridine Revenue, (US$, Mn), 2017-2028
Figure 25. France Dalfampridine Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Dalfampridine Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Dalfampridine Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Dalfampridine Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Dalfampridine Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Dalfampridine Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Dalfampridine Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Dalfampridine Sales Market Share, 2017-2028
Figure 33. China Dalfampridine Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Dalfampridine Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Dalfampridine Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Dalfampridine Revenue, (US$, Mn), 2017-2028
Figure 37. India Dalfampridine Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Dalfampridine Revenue Market Share, 2017-2028
Figure 39. By Country - South America Dalfampridine Sales Market Share, 2017-2028
Figure 40. Brazil Dalfampridine Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Dalfampridine Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Dalfampridine Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Dalfampridine Sales Market Share, 2017-2028
Figure 44. Turkey Dalfampridine Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Dalfampridine Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Dalfampridine Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Dalfampridine Revenue, (US$, Mn), 2017-2028
Figure 48. Global Dalfampridine Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Dalfampridine by Region, 2021 VS 2028
Figure 50. Dalfampridine Industry Value Chain
Figure 51. Marketing Channels